Market Overview:
The global diagnostic testing of STDs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of STDs, growing awareness about early diagnosis and treatment, and technological advancements in diagnostic testing methods. Based on type, the global diagnostic testing of STDs market is segmented into chlamydia testing, gonorrhea testing, P&S syphilis testing, HPVtesting HSVtesting HIVtesting Chancroidtesting. Chlamydia Testing held the largest share in 2017 and is projected to grow at a CAGR of 7% during the forecast period from 2018-2030. This can be attributed to rising prevalence rates for chlamydia infections across all regions globally coupled with increasing demand for accurate and rapid tests for diagnosis.
Product Definition:
Diagnostic testing of STDs is the process of identifying an infection by a sexually transmitted disease (STD) in order to receive treatment. The importance of diagnostic testing for STDs is that it can help prevent the spread of the infection and also help ensure that any treatments received are effective.
Chlamydia testing:
Chlamydia testing is a laboratory test that diagnoses diseases of the urinary tract, reproductive organs, and the gastrointestinal tract. It also checks for infections in the urethra and cervix. Chlamydia trachomatis (chlamydia) is a common bacterial infection found in women as well as men. The disease can be cured with antibiotics but it can be detected early using this method.
Gonorrhea testing:
Gonorrhea testing is the process of detection of gonococcal infections. Gonorrhea is a communicable disease caused by Neisseria gonorrhoeae bacteria. The major symptoms associated with this infection are urinary tract infection, pelvic pain, and abnormal discharge from the penis or vagina. According to CDC (Centers for Disease Control and Prevention), around 5,000 cases of gonorrhea are diagnosed every year in U.S.
Application Insights:
The hospitals segment dominated the global diagnostic testing of STD market in 2017. This is owing to factors such as high volume of patient admissions for diagnosis and treatment, availability of advanced healthcare facilities and highly skilled personnel, and an increase in the number of research studies related to STDs. For instance, according to a study published by CDC in 2014, around 47.0% out-of-hospital sexual transmission of HIV had been reported during 2012-2013 among black African populations aged 15-44 years living in 14 U.S states and Washington D.C., which indicated a need for increased awareness about HIV infection among individuals aged 18 years or above along with increasing access to effective prevention measures such as condoms usage amongst both heterosexuals & homosexuals. Thus, rising prevalence rates coupled with increasing awareness about safe sex practices are boosting demand for diagnostics tests across the Hospitals segment globally thereby contributing towards revenue growth globally within this segmented market category over the forecast period (2018 - 2030).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to rising prevalence of sexually transmitted diseases, increasing government initiatives and awareness campaigns regarding testing & treatment, and availability of advanced products in this region. For instance, as per a CDC fact sheet published in 2016; Chlamydia is the most commonly reported notifiable disease for all U.S states and territories. In addition, Gonorrhea has been on the rise since 2010 in North America with almost 1 million infections diagnosed each year according to statistics published by The National Institute for Health & Care Excellence (NICE).
Growth Factors:
- Increasing incidence of sexually transmitted diseases (STDs)
- Growing awareness about the benefits of early diagnosis and treatment of STDs
- Rising demand for rapid, accurate, and reliable diagnostic tests for STDs
- Technological advancements in diagnostic testing for STDs
- Growing number of private clinics and laboratories offering diagnostic testing services for STDs
Scope Of The Report
Report Attributes
Report Details
Report Title
Diagnostic Testing of STDs Market Research Report
By Type
Chlamydia testing, Gonorrhea testing, P&S Syphilis testing, HPV testing, HSV testing, HIV testing, Chancroid testing
By Application
Hospitals, Clinics
By Companies
Roche, Abbott, Becton Dickinson, BioMerieux, Danaher, Hologic, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Diagnostic Testing of STDs Market Report Segments:
The global Diagnostic Testing of STDs market is segmented on the basis of:
Types
Chlamydia testing, Gonorrhea testing, P&S Syphilis testing, HPV testing, HSV testing, HIV testing, Chancroid testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- Becton Dickinson
- BioMerieux
- Danaher
- Hologic
- Roche
Highlights of The Diagnostic Testing of STDs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chlamydia testing
- Gonorrhea testing
- P&S Syphilis testing
- HPV testing
- HSV testing
- HIV testing
- Chancroid testing
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diagnostic Testing of STDs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diagnostic testing of sexually transmitted diseases (STDs) is the process of determining whether a person has an STD. This can include taking a blood sample, doing a pelvic exam, or having an STD test done in the laboratory.
Some of the key players operating in the diagnostic testing of stds market are Roche, Abbott, Becton Dickinson, BioMerieux, Danaher, Hologic, Roche.
The diagnostic testing of stds market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diagnostic Testing of STDs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diagnostic Testing of STDs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diagnostic Testing of STDs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diagnostic Testing of STDs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diagnostic Testing of STDs Market Size & Forecast, 2020-2028
4.5.1 Diagnostic Testing of STDs Market Size and Y-o-Y Growth
4.5.2 Diagnostic Testing of STDs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chlamydia testing
5.2.2 Gonorrhea testing
5.2.3 P&S Syphilis testing
5.2.4 HPV testing
5.2.5 HSV testing
5.2.6 HIV testing
5.2.7 Chancroid testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diagnostic Testing of STDs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diagnostic Testing of STDs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chlamydia testing
9.6.2 Gonorrhea testing
9.6.3 P&S Syphilis testing
9.6.4 HPV testing
9.6.5 HSV testing
9.6.6 HIV testing
9.6.7 Chancroid testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chlamydia testing
10.6.2 Gonorrhea testing
10.6.3 P&S Syphilis testing
10.6.4 HPV testing
10.6.5 HSV testing
10.6.6 HIV testing
10.6.7 Chancroid testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chlamydia testing
11.6.2 Gonorrhea testing
11.6.3 P&S Syphilis testing
11.6.4 HPV testing
11.6.5 HSV testing
11.6.6 HIV testing
11.6.7 Chancroid testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chlamydia testing
12.6.2 Gonorrhea testing
12.6.3 P&S Syphilis testing
12.6.4 HPV testing
12.6.5 HSV testing
12.6.6 HIV testing
12.6.7 Chancroid testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chlamydia testing
13.6.2 Gonorrhea testing
13.6.3 P&S Syphilis testing
13.6.4 HPV testing
13.6.5 HSV testing
13.6.6 HIV testing
13.6.7 Chancroid testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diagnostic Testing of STDs Market: Competitive Dashboard
14.2 Global Diagnostic Testing of STDs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Abbott
14.3.3 Becton Dickinson
14.3.4 BioMerieux
14.3.5 Danaher
14.3.6 Hologic
14.3.7 Roche
